Abstract
The available bibliographic sources on the study of the veterinary drugs use effectiveness for mastitis treatment in cows in various physiological periods are analyzed. The use of anti-mastitis drugs for lactating and dry cows’ treatment is highlighted. Mastitis incidence in cows and relative study of the treatment mode for mastitis in the lactation and dry periods with the use of new drugs developed by Oryol SAU in cooperation with Experimental and Technological Company Etris, LLC is analyzed. In the experiment, the therapeutic efficacy of new anti-mastitis drugs was found to be 5-6% higher compared to those used on the farm. For high therapeutic efficacy, dosage scheme to be strictly followed, which will reduce the material costs for treatment.
Highlights
Dairy cattle breeding is an important link in the economic development of the farming sector
The frequency of each pathology in animals increases due to the intensification of milk production, concentration of animals groups in limited areas, violating sanitary and hygienic standards for animal housing, an increase in the milk productivity of cows and others
Disease incidence is in the range of 5 to 50 % of the dairy herd, and in some herds is even higher
Summary
Dairy cattle breeding is an important link in the economic development of the farming sector. In modern requirement of dairy stockbreeding, illness in cattle cause essential economic loss to complex. Obstetric and gynecological pathology, breast inflammation (mastitis) and diseases of the distal extremities are the most common pathologies. The frequency of each pathology in animals increases due to the intensification of milk production, concentration of animals groups in limited areas, violating sanitary and hygienic standards for animal housing, an increase in the milk productivity of cows and others. Mastitis is recorded regularly in groups at dairy units and farms around the world. Disease incidence is in the range of 5 to 50 % of the dairy herd, and in some herds is even higher
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
